Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Quantinno Capital Management LP

Quantinno Capital Management LP raised its position in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 11.2% during the 4th quarter, Holdings Channel.com reports. The firm owned 8,724 shares of the biotechnology company’s stock after acquiring an additional 878 shares during the quarter. Quantinno Capital Management LP’s holdings in Axon Enterprise were worth $5,185,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in AXON. New Wave Wealth Advisors LLC purchased a new stake in shares of Axon Enterprise in the 4th quarter valued at approximately $40,000. Y.D. More Investments Ltd acquired a new position in Axon Enterprise in the 4th quarter valued at $45,000. Stonebridge Financial Group LLC acquired a new stake in Axon Enterprise in the 4th quarter worth $53,000. GPS Wealth Strategies Group LLC grew its position in Axon Enterprise by 74.1% in the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock worth $56,000 after purchasing an additional 40 shares during the last quarter. Finally, Berbice Capital Management LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter valued at about $59,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Up 0.7%

Shares of NASDAQ AXON opened at $733.18 on Friday. The firm has a market cap of $57.08 billion, a PE ratio of 189.45, a price-to-earnings-growth ratio of 5.17 and a beta of 1.24. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $735.68. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a 50 day simple moving average of $584.61 and a 200 day simple moving average of $594.51.

Axon Enterprise (NASDAQ:AXONGet Free Report) last released its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The company had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. During the same quarter in the previous year, the company earned $1.15 EPS. Axon Enterprise’s quarterly revenue was up 31.3% compared to the same quarter last year. On average, research analysts forecast that Axon Enterprise, Inc. will post 5.8 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on AXON shares. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Northcoast Research cut shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a “buy” rating in a research report on Wednesday. Needham & Company LLC increased their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a “buy” rating in a research report on Thursday, May 8th. Finally, Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $652.73.

Get Our Latest Analysis on Axon Enterprise

Insiders Place Their Bets

In related news, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction dated Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the completion of the transaction, the chief executive officer now owns 3,063,982 shares in the company, valued at approximately $1,657,583,622.18. This represents a 0.33% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, President Joshua Isner sold 9,000 shares of the stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $683.31, for a total transaction of $6,149,790.00. Following the transaction, the president now owns 308,714 shares of the company’s stock, valued at $210,947,363.34. This represents a 2.83% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 23,764 shares of company stock worth $14,856,635. Insiders own 4.40% of the company’s stock.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

See Also

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.